System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Tienhan Sandrine Dabakuyo-Yonli is an expert in Oncology at Centre Georges François Leclerc (France). Tienhan Sandrine Dabakuyo-Yonli has authored 135 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 469 (community average: 125). How the SLR is computed.

LeadR Profile

Tienhan Sandrine Dabakuyo-Yonli Centre Georges François Leclerc France
469 ScienceLeadR Reputation 469

Unlock

Register Login
Network Map

Oncology

Subspecialties: Public Health - Gynecology - Pulmonology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026
Source: PubMed

Centre Georges François Leclerc

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 135

Citations

Citations: 3 235 1st author: 9 Last author: 33 Unique author: 0

Main journals

Rev Epidemiol Sante Publique 9
Ann Oncol 6
Cancer Res 5
Cancers (Basel) 5
BMC Cancer 4

Best Journals

N Engl J Med 3
Lancet Oncol 2
Lancet Child Adolesc Health 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Variation in net survival and in the excess mortality hazard for breast cancer according to stage and age at diagnosis.
PMID 42660022 — mortality, breast neoplasms, neoplasms, aged, breast, diagnosis		Cancer Epidemiol20260
Are older women with early-stage endometrial cancer undertreated and more likely to die from their cancer?
PMID 41043284 — comorbidity, neoplasms, aged, climacteric, histology, therapeutics, menopause, geriatrics, endometrial neoplasms		Maturitas20250
Characteristics, management and factors associated with poor outcomes in COVID-19 patients in Burkina Faso: insights from a 2021 large-scale ambispective study.
PMID 40709029 — comorbidity, public health, covid-19, therapeutics		Front Public Health20250
Advanced Epithelial Ovarian Cancer: Have We Really Improved Care for Patients Aged 70 Years and Older? A 20-year Registry-based Study.
PMID 40446384 — registries, ovary, neoplasms, aged, ovarian neoplasms, therapeutics, carcinoma, ovarian epithelial		Clin Oncol (R Coll Radiol)20250
Effects of the right to be forgotten for childhood or breast cancer survivors: results of a quasi-experimental study in France.
PMID 40467965 — financial stress, cancer survivors, breast neoplasms, neoplasms, insurance, breast, non-randomized controlled trials as topic		J Cancer Surviv20251

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 4
Phase 1 1
Phase 2 1

By status:

Completed 4
Recruiting 1
Terminated 1

By type:

Interventional 5
Observational 1

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Health Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer
NCT04176809 — quality of life, breast neoplasms, neoplasms, tablets, diet, solutions, fatigue, breast, therapeutics, software		N/ARecruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS